Search research articles
Contact Us
Filters
Showing results (441-450 of 673) with videos related to
Page
of 68
Sort By:
Cardiovascular Drugs and Therapy
|
January 20, 2016
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation
Michael V Cohen, Xi-Ming Yang, James White, et al.
Obesity Surgery
|
August 22, 2022
Correction to: Innovative Bariatric Procedures and Ethics in Bariatric Surgery: The IFSO Position Statement
Ashraf Haddad, Lilian Kow, Miguel F Herrera, et al.
The American Journal of Cardiology
|
April 12, 2000
The electrocardiogram in morbid obesity
M A Alpert, B E Terry, M V Cohen, et al.
Obesity Surgery
|
May 14, 2025
Reframing Obesity: Physiological Mechanisms, Clinical Diagnosis, and Implications for Metabolic Bariatric Surgery
Bart Torensma, Mohamed Hany, Edo Aarts, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications
Justine V Cohen, Adam Adika, Matthew Zibelman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2000
Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center
K Maher, N Klimas, M A Fletcher, et al.
British Journal of Pharmacology
|
March 4, 2011
A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin
Xiulan Yang, Wenkuan Xin, Xi-Ming Yang, et al.
Cardiovascular Research
|
May 1, 1996
Infarct limitation of the second window of protection in a conscious rabbit model
X M Yang, G F Baxter, R J Heads, et al.
Revista Paulista De Medicina
|
May 1, 1986
[Treatment of post-traumatic hemobilia by arterial embolization]
S Rasslan, F Rahal, R Saad Júnior, et al.
European Journal of Endocrinology
|
June 9, 2019
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis
Alexander Faje, Kerry Reynolds, Leyre Zubiri, et al.
Page
of 68
Search research articles
Search
Showing results (441-450 of 673) with videos related to
Sort By:
Page
of 68
Cardiovascular Drugs and Therapy
|
January 20, 2016
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation
Michael V Cohen, Xi-Ming Yang, James White, et al.
Obesity Surgery
|
August 22, 2022
Correction to: Innovative Bariatric Procedures and Ethics in Bariatric Surgery: The IFSO Position Statement
Ashraf Haddad, Lilian Kow, Miguel F Herrera, et al.
The American Journal of Cardiology
|
April 12, 2000
The electrocardiogram in morbid obesity
M A Alpert, B E Terry, M V Cohen, et al.
Obesity Surgery
|
May 14, 2025
Reframing Obesity: Physiological Mechanisms, Clinical Diagnosis, and Implications for Metabolic Bariatric Surgery
Bart Torensma, Mohamed Hany, Edo Aarts, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications
Justine V Cohen, Adam Adika, Matthew Zibelman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2000
Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center
K Maher, N Klimas, M A Fletcher, et al.
British Journal of Pharmacology
|
March 4, 2011
A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin
Xiulan Yang, Wenkuan Xin, Xi-Ming Yang, et al.
Cardiovascular Research
|
May 1, 1996
Infarct limitation of the second window of protection in a conscious rabbit model
X M Yang, G F Baxter, R J Heads, et al.
Revista Paulista De Medicina
|
May 1, 1986
[Treatment of post-traumatic hemobilia by arterial embolization]
S Rasslan, F Rahal, R Saad Júnior, et al.
European Journal of Endocrinology
|
June 9, 2019
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis
Alexander Faje, Kerry Reynolds, Leyre Zubiri, et al.
Page
of 68